Overview of the Spinal Muscular Atrophy (SMA) Treatment Market
This market research report offers detailed market analysis, industry insights, and growth forecasts for the Spinal Muscular Atrophy (SMA) Treatment industry. It includes qualitative and quantitative research, competitive intelligence, and key market trends. Designed to support strategic planning, the report covers market segmentation, share data, and emerging opportunities—ideal for businesses, investors, and analysts seeking reliable data to inform decisions and understand the competitive landscape.
Download your free sample PDF of the report -
Scope of the Report
- Market size and revenue (current & projected)
- Growth trends backed by real data
- Competitive landscape and who’s leading
- Opportunities and threats worth noting
Key Findings and Insights Market Size and Growth
The Global Spinal Muscular Atrophy (SMA) Treatment Market size was valued at around USD 2.3 billion in 2023 and is projected to reach around USD 30.2 billion by 2030. Along with this, the market is anticipated to grow at a CAGR of around 18.2% during the forecast period, i.e., 2025-30.
Key Factors Driving Growth
Growing Incidence of the Disorder to Augment the Market – In terms of cost and healthcare services, the overall burden of spinal muscular atrophy is one of the highest in the rare disorder. With multiple incidences of spinal muscular atrophy popping up due to the increase in population, the requirement for SMA treatment is growing drastically on a global level. As per the Spinal Muscular Atrophy Foundation estimations, 1 in every 6000 to 10000 babies are diagnosed with this, despite being considered a rare disorder.
Browse More About This Research Report – https://www.marknteladvisors.com/research-library/spinal-muscular-atrophy-sma-treatment-market.html
Spinal Muscular Atrophy (SMA) Treatment Market Segmentation Insight (2025-30)
Break down the market into key segments such as:
By Type
- Type I- Market Size & Forecast 2020-2030, USD Million
- Type II- Market Size & Forecast 2020-2030, USD Million
- Type III- Market Size & Forecast 2020-2030, USD Million
- Type IV- Market Size & Forecast 2020-2030, USD Million
SMA Type I has the largest number of SMA patients accounting for about 60% of them worldwide, according to the National Organization for Rare Disorders.
By Treatment
- Gene Therapy- Market Size & Forecast 2020-2030, USD Million
- Disease-Modifying Drugs- Market Size & Forecast 2020-2030, USD Million
In the Global Spinal Muscular Atrophy (SMA) Treatment Market gene therapy segment holds a market share of over 70%.
By Drug Type
- Nusinersen- Market Size & Forecast 2020-2030, USD Million
- Onasemnogene Abeparvovec- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
By Route of Administration
- Oral- Market Size & Forecast 2020-2030, USD Million
- Injectable- Market Size & Forecast 2020-2030, USD Million
By Distribution Channel
- Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
By End User
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Homecare- Market Size & Forecast 2020-2030, USD Million
- Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
North America is dominating the Global Spinal Muscular Atrophy Market accounting for more than 40% market share in 2024.
Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Notable Industry Key Players
Get detailed profiles and strategic insights on major companies shaping the market, including:
- Biogen
- Novartis AG
- Hoffmann-La Roche Ltd
- Cytokinetics
- PTC Therapeutics, Inc.
- Ionis Pharmaceuticals Inc.
- Astellas Pharma Inc.
- NMD Pharma A/S
- Genzyme Corporation
- Genentech, Inc.
- Pfizer Inc.
- Scholar Rock Holding Corporation
- Novo Nordisk A/S
- Takeda Pharmaceutical Co. Ltd.
Request Methodology
- Robust methodology ensures accuracy and minimizes forecast deviations.
- Top-down and bottom-up analysis for precise market segmentation.
- Multi-angle data triangulation enhances reliability of insights.
- Expert-led primary research through surveys, interviews, and more.
- Predictive modeling delivers forward-looking market intelligence.
Key Questions Answered in This Market Research Report
- What is the current market size and total valuation?
- How fast is the market expected to grow in the coming years?
- What are the latest trends influencing the market?
- Which factors are driving or restraining market growth?
- How is the market segmented and geography?
- Who are the key players and what strategies are they adopting?
- What does the competitive landscape look like?
- Which regions offer the highest growth opportunities?
- What opportunities and challenges should stakeholders prepare for?
About Us:
MarkNtel Advisors is a global market research company, with a notable presence in key markets such as USA, Europe, Southeast Asia, UK, GCC, Asia, and more.
We take pride in our ability to cover diverse industry through our comprehensive range of market research services.\
Get in Touch:
Email - sales@marknteladvisors.com
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India